Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

ASH 2021 | The impact of CHIP in Alzheimer’s disease risk

Siddhartha Jaiswal • 12 Dec 2021

ASH 2021

General

Clonal hematopoiesis of indeterminate potential (CHIP) is a precursor state for many blood cancers and it has also been associated with chronic inflammatory diseases of aging. In this video, Siddhartha Jaiswal, MD, PhD, Stanford University, Stanford, CA, comments on the results of a study investigating the association between CHIP and Alzheimer’s disease (AD). The study found that CHIP was correlated with a reduced risk of AD. In addition, it was shown that seven out of eight CHIP carriers had evidence of mutations in their microglial pool, and further analysis in two of these carriers showed that 40-80% of microglia had been replaced by mutated precursors, which may provide a protective effect in AD. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Investigating the effect of CHIP mutations in microglial function and Alzheimer’s disease

Siddhartha Jaiswal • 12 Dec 2021

CHIP is robustly associated with protection from Alzheimer’s disease

Siddhartha Jaiswal • 10 Dec 2021

Jaiswal lab research and updates: mutations and age-related disease

Siddhartha Jaiswal • 25 Feb 2019

Clonal hematopoiesis of indeterminate potential (CHIP): genes, disease predisposition & potential

Siddhartha Jaiswal • 25 Feb 2019

Related Videos

The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024

Natacha Bolaños • 16 Apr 2024

Distinguishing late-onset neutropenia from classical primary neutropenia

Carlo Dufour • 15 Apr 2024

The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract

James Ferrara • 16 Apr 2024

The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives

Claire Horgan • 15 Apr 2024